LUPKYNIS Drug-use Results Survey
Recruiting
Observational Study
Lupus Nephritis
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 15 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 400 (estimated)
- Sponsor
- Otsuka Pharmaceutical Co., Ltd. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to survey the safety of LUPKYNIS in patients with lupus nephritis under actual use conditions. In addition, information on efficacy will be collected.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients who are newly starting administration of LUPKYNIS for lupus nephritis
Exclusion Criteria:
\-
Contacts
Pharmacovigilance Department Otsuka Pharmaceutical Co., Ltd
+81-6-6943-7722
CONTACT